Related Experiment Video
Updated: Apr 26, 2026

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
Subclassification of left ventricular hypertrophy based on dilation stratifies coronary artery disease patients with
Bao-Tao Huang1, Yong Peng, Wei Liu
1Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Insights
Dilated left ventricular hypertrophy (LVH) in coronary artery disease (CAD) patients indicates worse outcomes. Eccentric dilated LVH showed the highest risk for death and composite events, while eccentric nondilated LVH did not predict adverse events.
Area of Science:
- Cardiology
- Echocardiography
- Clinical Outcomes
Background:
- A novel 4-tiered classification for left ventricular hypertrophy (LVH) categorizes geometry by concentricity and dilation.
- The prognostic implications of this LVH classification in patients with coronary artery disease (CAD) remain unclear.
Purpose of the Study:
- To investigate the association between LV geometry patterns and clinical outcomes in patients with CAD.
- To determine if the new LVH classification provides distinct prognostic information.
Main Methods:
- Echocardiographic assessment of left ventricular mass (LVM) and end-diastolic volume (EDV) in 2297 CAD patients.
- Classification of LV geometry into five groups: eccentric nondilated LVH, eccentric dilated LVH, concentric nondilated LVH, concentric dilated LVH, and normal LV mass.
- Analysis of all-cause death and composite events using Cox regression.
Main Results:
- Dilated LVH (both eccentric and concentric) was associated with significantly higher rates of all-cause death and composite events compared to nondilated LVH.
- Eccentric dilated LVH demonstrated the highest risk for all-cause death (aHR 2.752) and composite events (aHR 2.462).
- Eccentric nondilated LVH showed comparable risks for adverse outcomes to normal LV mass.
Conclusions:
- LVH geometry, specifically dilation, provides significant and distinct prognostic information in patients with CAD.
- Eccentric nondilated LVH is not associated with adverse outcomes.
- The classification aids in risk stratification for CAD patients with LVH.
Background:
A new 4-tired classification of left ventricular hypertrophy (LVH) based on LV concentricity and dilation has been proposed; however, the association between the new categorization of LV geometry and outcomes in patients with coronary artery disease (CAD) is still unknown.
Methods:
All the 2297 patients with CAD included underwent echocardiographic examination prior to discharge. Left ventricular mass (LVM) was calculated, and left ventricular end-diastolic volume (EDV) was indexed by body surface area (BSA). Study cohort was divided into five groups according to LV geometry: (i) eccentric nondilated LVH (normal LVM/EDV((2/3)) and EDV/BSA) (n = 129); (ii) eccentric dilated LVH (normal LVM/EDV((2/3)) with increased EDV/BSA) (n = 222); (iii) concentric nondilated LVH (increased LVM/EDV((2/3)) with normal EDV/BSA) (n = 441); (iv) concentric dilated LVH (increased LVM/EDV((2/3)) and EDV/BSA) (n = 118); and (v) normal LV mass (n = 1387).
Results:
Dilated LVH was associated with a higher event rates of all-cause death (eccentric 13·1% vs. 3·1%; concentric 13·6% vs. 8·4%) and composite events (eccentric: 17·6% vs. 5·4%; concentric: 18·6% vs. 12·7%) compared with nondilated LVH. While eccentric nondilated LVH had comparable risk for adverse outcomes compared with normal LV mass (all-cause death: relative risk (RR) 0·68, 95% confidential interval (CI) 0·25-1·85; composite events: RR 0·75, 95% CI 0·36-1·58). Cox regression analyses showed that eccentric dilated LVH had the highest propensity to all-cause death (adjusted hazard ratio [aHR] 2·752 [95% CI 1·749-4·328], P < 0·001) and composite events (aHR 2·462 [95% CI 1·688-3·592], P < 0·001).
Conclusion:
In patients with CAD, dilated LVH and nondilated LVH provide distinct prognostic information. Eccentric nondilated LVH does not predict adverse outcomes.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

